Elevers delaktighet i planeringen i ämnet Idrott och Hälsa

Syfte Syftet med intervjuundersökningen var att ta reda på om eleverna medverkar i planeringen i ämnet Idrott och Hälsa och vad de kan påverka. Delaktighet har olika innebörder i olika sammanhang, delaktighet i yrkeslivet kan handla om arbetsmoral och delaktighet i skolan om integrering eller elevinflytande. Metod 6 elever i åk 4-6 intervjuades i en ostrukturerad intervjuundersökning där de först deltog i en gruppdiskussion. Från dessa sex elever gjordes ett urval där tre elever fick medverka i en personlig intervjuundersökning för att ta reda på hur väl eleverna kände sig delaktiga och vilket inflytande de hade i skolan i planeringen inom ämnet Idrott och Hälsa . Vid intervjutillfället användes papper och penna. Resultat Eleverna ansåg att läraren bestämmer det mesta i innehållet i ämnet Idrott och Hälsa. De aktiviteter eleverna hade varit med och planerat med läraren var olika lekar och bollsporter. Eleverna ansåg det var viktigt att de fick vara delaktiga på hur gruppindelningen skulle se ut. Uppvärmningen var en aktivitet som eleverna tyckte att de kunde utföra och planera själva varje lektion. Bollsporter var ett måste om eleverna själva skulle skriva om kursplanen

Två tillstånd som inte bara psykiatrer bör känna till : Malignt neuroleptikasyndrom och serotonergt syndrom är två tillstånd som det är viktigt att även andra läkare än psykiatrer tänker på och känner igen

Malignt neuroleptikasyndrom och serotonergt syndrom är två tillstånd som det är viktigt att även andra läkare än psykiatrer tänker på och känner igen. Petra Truedsson och medförfattare beskriver helt riktigt i en översikt i Läkartidningen [1] att det skulle behövas bättre kvalitet i det vetenskapliga underlaget för behandling av dessa tillstånd, i synnerhet för malignt neuroleptikasyndrom som är förenat med risk för komplikationer och i svåra fall mortalitet

Response rate and subjective memory after electroconvulsive therapy in depressive disorders with psychiatric comorbidity

Background: Response rates after and tolerability of electroconvulsive therapy (ECT) in depressive disorders with psychiatric comorbidity are uncertain. Methods: Data on patients with a depressive episode and a first course of ECT were collected from the Swedish National Quality Register for ECT. Logistic regression analyses, adjusted for gender, age, and depressive episode severity, were used to compare patients with and without comorbidity. The clinical response assessment Clinical Global Impression - Improvement Scale was used in 4413 patients and the memory item from the Comprehensive Psychiatric Rating Scale was used for subjective memory impairment rating after ECT in 3497 patients. Results: In patients with depressive disorder and comorbid personality disorder or anxiety disorder, 62.7% and 73.5%, respectively, responded after ECT compared with 84.9% in patients without comorbidity [adjusted odds ratio (aOR) 0.43, 95% confidence interval (CI) 0.34-0.55, and aOR 0.61, 95% CI 0.51-0.73, respectively]. The proportion of responding patients with comorbid alcohol use disorder was 77.1%, which was not significantly different from that in patients without comorbidity (aOR 0.75, 95% CI 0.57-1.01). The impact of comorbidity decreased with higher age and depressive episode severity. Subjective ratings of memory impairment did not differ between patients with and without comorbidity. Limitations: Observational non-validated clinical data. Conclusions: The response rate after ECT in depression may be lower with concurrent personality disorder and anxiety disorder; however, the majority still respond to ECT. This implies that psychiatric comorbidity should not exclude patients from ECT.Funding Agencies|Uppsala Universityhospitals research fund; Swedish Research CouncilSwedish Research CouncilEuropean Commission [201602362]</p

Improvement of cycloid psychosis following electroconvulsive therapy

Background: The treatment of choice for cycloid psychosis has traditionally been electroconvulsive therapy (ECT), but there is a lack of studies on its effectiveness. Aims: The primary aim of this register study was to determine the rates of remission and response after ECT for cycloid psychosis. The secondary aim was to examine possible predictors of outcome. Methods: Data were obtained from the National Quality Register for ECT in Sweden. The study population was patients (n=42) who received ECT for acute polymorphic psychotic disorder without symptoms of schizophrenia or for cycloid psychosis between 2011-2015 in 13 hospitals. Remission and response rates were calculated using Clinical Global Impression-Severity (CGI-S) and -Improvement scores, respectively. Variables with possible predictive value were tested using Chi-square and Fisher's exact test. Results: The response rate was 90.5%. The remission rate was 45.2%. Of 42 patients, 40 improved their CGI-S score after ECT (p&lt;0.001). The mean number of ECT treatments was 2.5 for non-responders and 7.0 for responders (p=0.010). The mean number of ECT treatments did not differ significantly between remitters and non-remitters (7.2 vs 6.1, p=0.31). None of the other investigated potential predictors was statistically significantly associated with outcome. Conclusions: ECT is an effective treatment for cycloid psychosis. Future studies need to compare the outcome of ECT to that of other treatment strategies. Clinical implications: The high response rate with ECT indicates that cycloid psychosis is a clinically useful diagnosis

Racemic Ketamine as an Alternative to Electroconvulsive Therapy for Unipolar Depression : A Randomized, Open-Label, Non-Inferiority Trial (KetECT)

Background Ketamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared with electroconvulsive therapy (ECT), the most effective therapy for depression. Methods Hospitalized patients with unipolar depression were randomized (1:1) to thrice-weekly racemic ketamine (0.5 mg/kg) infusions or ECT in a parallel, open-label, non-inferiority study. The primary outcome was remission (Montgomery angstrom sberg Depression Rating Scale score &amp;lt;= 10). Secondary outcomes included adverse events (AEs), time to remission, and relapse. Treatment sessions (maximum of 12) were administered until remission or maximal effect was achieved. Remitters were followed for 12 months after the final treatment session. Results In total 186 inpatients were included and received treatment. Among patients receiving ECT, 63% remitted compared with 46% receiving ketamine infusions (P = .026; difference 95% CI 2%, 30%). Both ketamine and ECT required a median of 6 treatment sessions to induce remission. Distinct AEs were associated with each treatment. Serious and long-lasting AEs, including cases of persisting amnesia, were more common with ECT, while treatment-emergent AEs led to more dropouts in the ketamine group. Among remitters, 70% and 63%, with 57 and 61 median days in remission, relapsed within 12 months in the ketamine and ECT groups, respectively (P = .52). Conclusion Remission and cumulative symptom reduction following multiple racemic ketamine infusions in severely ill patients (age 18-85 years) in an authentic clinical setting suggest that ketamine, despite being inferior to ECT, can be a safe and valuable tool in treating unipolar depression.Funding Agencies|Swedish Research Council [2015-00799]; Crafoord Foundation; Skane Regional Council; Konigska Foundation; Lions forsknings foundation Skane; OM Perssons donation foundation</p